ibuprofen has been researched along with Cancer of Pancreas in 3 studies
Midol: combination of cinnamedrine, phenacetin, aspirin & caffeine
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients with irresectable pancreatic cancer (n = 16) were treated with either ibuprofen (1200 mg day-1 for 7 days (n = 10) or placebo (n = 6)." | 2.68 | Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients. ( Carter, DC; Falconer, JS; Fearon, KC; Maingay, JP; Plester, CE; Ross, JA; Wigmore, SJ, 1995) |
| "Smoking is a documented risk factor for pancreatic cancer, and the risk is increased in smokers who also consume alcohol." | 1.31 | The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK. ( Castonguay, A; Miller, MS; Schuller, HM; Walker, K; Weddle, DL; Zhang, L, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thakkar, A | 1 |
| Chenreddy, S | 1 |
| Wang, J | 1 |
| Prabhu, S | 1 |
| Schuller, HM | 1 |
| Zhang, L | 1 |
| Weddle, DL | 1 |
| Castonguay, A | 1 |
| Walker, K | 1 |
| Miller, MS | 1 |
| Wigmore, SJ | 1 |
| Falconer, JS | 1 |
| Plester, CE | 1 |
| Ross, JA | 1 |
| Maingay, JP | 1 |
| Carter, DC | 1 |
| Fearon, KC | 1 |
1 trial available for ibuprofen and Cancer of Pancreas
| Article | Year |
|---|---|
Ibuprofen reduces energy expenditure and acute-phase protein production compared with placebo in pancreatic cancer patients.
Topics: Acute-Phase Proteins; Animals; C-Reactive Protein; Energy Metabolism; Female; Humans; Ibuprofen; Mal | 1995 |
2 other studies available for ibuprofen and Cancer of Pancreas
| Article | Year |
|---|---|
Evaluation of ibuprofen loaded solid lipid nanoparticles and its combination regimens for pancreatic cancer chemoprevention.
Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Surv | 2015 |
The cyclooxygenase inhibitor ibuprofen and the FLAP inhibitor MK886 inhibit pancreatic carcinogenesis induced in hamsters by transplacental exposure to ethanol and the tobacco carcinogen NNK.
Topics: Adenocarcinoma; Animals; Arachidonic Acid; Cricetinae; Cyclooxygenase Inhibitors; DNA Primers; Ethan | 2002 |